Vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection wanes over time, requiring updated boosters. In a phase 2, open-label, …

BACKGROUND & AIMS: The combination of pegylated interferon (IFN) α and ribavirin (RBV)
is the standard therapy for patients with chronic HCV infection. However, it produces a …

Several genome‐wide association studies (GWAS) have identified a genetic polymorphism
associated with the gene locus for interleukin 28B (IL28B), a type III interferon (IFN), as a …

Responses to alpha interferon (IFN-α)-based treatment are dependent on both host and
viral factors and vary markedly among patients infected with different hepatitis C virus (HCV) …

Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by
emerging variants including Omicron subvariants. This study evaluated safety and …

Background. We and others have shown that primary hepatitis C (HCV) infection in men
infected with human immunodeficiency virus (HIV) causes early-onset liver fibrosis; however, …

HCV replication disrupts normal endoplasmic reticulum (ER) function and activates a
signaling network called the unfolded protein response (UPR). UPR is directed by three ER …

The emergence of the COVID-19 epidemic in the United States (US) went largely undetected
due to inadequate testing. New Orleans experienced one of the earliest and fastest …

Many countries in sub-Saharan Africa have experienced lower COVID-19 caseloads and
fewer deaths than countries in other regions worldwide. Under-reporting of cases and a …

A 59-year-old male with follicular lymphoma treated by anti-CD20-mediated B-cell depletion
and ablative chemotherapy was hospitalized with a COVID-19 infection. Although the …